03/25/2026
I wrote a published article in the Journal of Heart and Lung Transplantation… and I still can’t quite believe I get to say that. 🤍
This isn’t just something I contributed to—I wrote it.
Every word comes from lived experience. From being a heart transplant recipient. From navigating medications like everolimus. From fighting insurance barriers that stand between patients and the treatments that keep us alive.
This article is science—but it’s also my story.
It’s the reality of what transplant patients face every day: not just surviving, but advocating, pushing, and refusing to be ignored when access to care is on the line.
I didn’t write this just for me.
I wrote it for every transplant patient who has had to fight to be heard.
I wrote it for my donor, Christian, whose heart gave me a second chance at life.
And I wrote it with deep love and respect for his mom, Mary.
Being published means something—but using my voice to create change means everything.
If you’d like to read it:
🔗 https://www.jhltonline.org/article/S1053-2498(26)01798-5/abstract
Thank you to everyone who has supported me through this journey. I’m just getting started.
Access to immunosuppressive therapy is essential for long-term survival in heart transplant recipients, yet insurance coverage does not always translate into meaningful access. This perspective introduces the concept of “ghost approval,” in which a medication is technically approved but remains ...